Rx · PZN 13921368, 16218988
KANJINTI 150 mg powder for a concentrate for preparation of a solution for infusion
German trade nameKANJINTI 150 mg Pulver für einer Konzentrat zur Herstellung einer Infusionslösung
No observed availability
0.0out of 10
Storage temperature and transport temperature
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for KANJINTI 150 mg powder for a concentrate for preparation of a solution for infusion.
Review purchasing termsKANJINTI 150 mg powder for a concentrate for preparation of a solution for infusion contains the active ingredient Trastuzumab. 2 pack sizes of this product are recorded. All packs reach a pharma availability index of 0.0 out of 10 over the past 30 days.
Pack sizes · 2 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 13921368 | 0.0 | 0.0 | ~ €209 |
| 16218988 | 0.0 | 0.0 | ~ €209 |
KANJINTI 150 mg powder for a concentrate for preparation of a solution for infusion was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.
Request a source of supply